Related Protocols
View all Cell therapy protocols
A bioluminescent mouse model using the human U266 cell line expressing green fluorescent protein and luciferase to monitor disease progression in vivo and assess bone marrow engraftment after intravenous NK-92 cell therapy
A novel xenogeneic bioluminescent Ph+ leukemia model
A rapid in vivo assay system for analyzing the organogenetic capacity of human kidney cells: preparation of human kidney cells and chorioallantoic membrane (CAM) grafting
Adoptive transfer of propagated T cells (canine model)
Adoptive T cell therapy : analysis of CD3-zeta signaling chimeric antigen receptor (CAR) mediated T cell activation and Synapse formation
Aldefluor Assay
ALDH as a marker for rapid isolation of murine and human myogenic progenitors for cell therapy: Human muscle cell isolation and Fluorescence activated cell sorting by ALDH activity
Allogeneic mixed lymphocyte reaction (MLR)
Amniotic epithelial cells (AEC) and tendon explants/tenocytes isolation and culture: Co-culture systems and AEC characterization
Analysis of co-culture induced amniotic epithelial cells (AEC) epithelial-mesenchymal transition
Angiogenic tests (proliferation of human umbilical vein endothelial (HUVEC) cells, sprouting test)
Apoptosis assay using cardiomyocytes
Assays for screening the efficacy of microglial precursor cells for treating glioma: Generation of microglial precursors from mouse embryonic stem cells (ESdM), Induction of experimental gliomas in a syngenic animal model to avoid immune reaction against allo-antigens expressed by the tumor, Intratumoral injection of microglial precursors into experimental gliomas, In vitro experiments with murine ESdM and glioma
Assays for screening the efficacy of adult bone marrow-derived somatic cells (ABM-SC) for treating cardiovascular, neurological, integumentary, dermatological, periodontal, and immune mediated diseases, disorders, pathologies, and injuries
Assays for characterizing spinal cord injury using amnion derived adherent cells (AMDACs)
Autologous CD34+ Cell Injection Procedure in Patients with Refractory Angina (phase II clinical trial study)
Bioluminescent imaging (BLI) of cells
Bone-marrow derived cell (BMDC) transplantion into non-irradiated c-kit receptor - deficient (W41) mdx mice (Duchenne muscular dystrophy (DMD))
Cardiomyotissue Implantation: Histological Analysis and Male-Into-Female Transplantation Model
CD107 Assays
